logo

For the Inventor, By the Inventor

Milpitas, CA, United States of America

Cordis Corporation


USPTO Granted Patents = 954

% Expired Patents = 11.1



Trademarks = 70

Forward Citations = 106,129

Loading Chart...
Loading Chart...

596 inventors (with patents filed for the assignee):

goldMedal David Christopher Majercak (46 out of 51 patents)

silverMedal Jonathon Zhong Zhao (36 out of 45 patents)

bronzeMedal Robert Falotico (28 out of 48 patents)

4.  Hikmat Hojeibane (27 out of 30 patents)

5.  Kirk L Johnson (27 out of 51 patents)

6.  Thomas N Trotta (25 out of 26 patents)

7.  Leonard Pinchuk (24 out of 149 patents)

8.  Robert Burgermeister (21 out of 32 patents)

9.  Richard A Hillstead (21 out of 56 patents)

10.  David R Fischell (20 out of 217 patents)

11.  Fernando M Viera (20 out of 20 patents)

12.  Jin S Park (19 out of 28 patents)

13.  Robert E Fischell (18 out of 208 patents)

14.  Peter P Tarjan (17 out of 22 patents)

15.  Kenneth S Solovay (16 out of 34 patents)


Core Competencies:
Stent Delivery System
Vascular Closure Device
Drug-Eluting Stents
Endovascular Devices
Total Occlusion Guidewire
Thin-Film Medical Device
Biocompatible Polymers
Therapeutic Agent Delivery
Aneurysm Stent-Graft
Catheter Systems
Bioabsorbable Devices
Flexible Stent Design

954 patents:

1. 10945716 - Patent foramen ovale closure method (2021-03-16),
2. 9861347 - Patent foramen ovale closure method (2018-01-09),
3. 9687366 - Endoleak mitigator for aneurysm stent-graft (2017-06-27),
4. 9579427 - Thin-film composite retrievable endovascular devices and method of use (2017-02-28),
5. 9555165 - Medical tubing for catheters (2017-01-31),
6. 9339368 - Thin film medical device and delivery system (2016-05-17),
7. 9290742 - Tissue engineered blood vessel (2016-03-22),
8. 9289198 - Locator and closure device and method of use (2016-03-22),
9. 9265598 - Local vascular delivery of sirolimus to prevent restenosis following vascular injury (2016-02-23),
10. 9254211 - Stent delivery system using a steerable guide wire (2016-02-09),
11. 9254201 - Device for loading self-expanding stents (2016-02-09),
12. 9168161 - Flexible stent design (2015-10-27),
13. 9155644 - Flexible helical stent having intermediate structural feature (2015-10-13),
14. 9149376 - Reconstrainable stent delivery system (2015-10-06),
15. 9114034 - Antithrombotic and anti-restenotic drug eluting stent (2015-08-25),
Cordis Corporation, headquartered in Milpitas, California, specializes in the development and manufacturing of advanced vascular devices. The company focuses on innovative solutions such as stent delivery systems, vascular closure devices, and drug-eluting stents, aimed at improving patient outcomes in cardiovascular care. With expertise in endovascular devices, total occlusion guidewires, and biocompatible polymers, Cordis is committed to enhancing therapeutic agent delivery and advancing the field of vascular intervention.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Cordis Corporation
954 Patents

#6 in Milpitas, CA

#129 in California

#542 in US

#1,070 in the World

Milpitas, CA (US)
Milpitas, CA, United States of America

Cordis Corporation

Forward Citations = 106,129

596 inventors:

goldMedal David Christopher Majercak (46 out of 51 patents)

silverMedal Jonathon Zhong Zhao (36 out of 45 patents)

bronzeMedal Robert Falotico (28 out of 48 patents)

4.  Hikmat Hojeibane (27 out of 30 patents)

5.  Kirk L Johnson (27 out of 51 patents)

Please report any incorrect information to [email protected]
Loading…